Century Therapeutics (IPSC) Retained Earnings (2020 - 2026)
Century Therapeutics (IPSC) posted quarterly Retained Earnings of -$813.6 million for Q1 2026, down 15.27% year-over-year from -$960.2 million in Q1 2025, and down 2.73% quarter-over-quarter from -$791.9 million in Q4 2025.
Century Therapeutics (IPSC) Retained Earnings (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Retained Earnings for 7 consecutive years, with -$813.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 15.27% year-over-year to -$813.6 million; the TTM figure through Mar 2026 stood at -$813.6 million (down 15.27% YoY), while the FY2025 annual figure was -$791.9 million, down 1.22% from the prior year.
- Retained Earnings eased to -$813.6 million in Q1 2026 per IPSC's latest filing, from -$791.9 million in the prior quarter.
- Across five years, Retained Earnings topped out at $758000.0 in Q3 2024 and bottomed at -$813.6 million in Q1 2026.
- Historically, Retained Earnings has averaged -$474.8 million across 5 years, with a median of -$550.4 million in 2023.
- Annual changes were most pronounced in 2022 — Retained Earnings plunged 15222133.33% — and 2025, when it jumped 126.86%.
- Century Therapeutics' Retained Earnings stood at -$519.1 million in 2022, then slipped by 26.33% to -$655.8 million in 2023, then retreated by 19.3% to -$782.3 million in 2024, then declined by 1.22% to -$791.9 million in 2025, then fell by 2.73% to -$813.6 million in 2026.
- Business Quant data shows IPSC's Retained Earnings at -$813.6 million in Q1 2026, -$791.9 million in Q4 2025, and $64000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | -848.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -848.11 Mn |
| Mar 31, 2026 | -813.56 Mn |
| Dec 31, 2025 | -791.92 Mn |
| Sep 30, 2025 | 64,000.00 |
| Jun 30, 2025 | 83,000.00 |
| Mar 31, 2025 | -705.78 Mn |
| Dec 31, 2024 | -782.34 Mn |
| Sep 30, 2024 | 758,000.00 |
| Jun 30, 2024 | -309,000.00 |
| Mar 31, 2024 | -683.83 Mn |
| Dec 31, 2023 | -655.77 Mn |
| Sep 30, 2023 | -616.37 Mn |
| Jun 30, 2023 | -583.65 Mn |
| Mar 31, 2023 | -550.36 Mn |
| Dec 31, 2022 | -519.10 Mn |
| Sep 30, 2022 | -487.42 Mn |
| Jun 30, 2022 | -456.67 Mn |
| Mar 31, 2022 | -425.68 Mn |
| Dec 31, 2021 | -650,000.00 |
| Sep 30, 2021 | -63,000.00 |